Clinical Trial Update: A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases [Phase 1]

View source ↗

Summary

Amgen reported completion of a Phase 1 study of MEDI7734 in Type I interferon-mediated autoimmune diseases, including dermatomyositis, polymyositis, Sjögren's s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Polymyositis
• Sjögren Syndrome
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• MEDI7734

Snippet

Sponsor: Amgen | Conditions: Dermatomyositis, Polymyositis, Sjogren's, SLE, SSc | Phase 1 | Status: COMPLETED